CYP19A1 and breast carcinoma: This altered adipokine balance has been postulated to drive the increased expression of aromatase in obese adipose stromal cells leading to an increase in biotransformation of androgenic substrates into estrogens (49, 50), and coincides with higher incidence of ER+ breast cancer in obese patients (46, 48).